Literature DB >> 17570989

The prevalence of metabolic syndrome in various populations.

Genovefa D Kolovou1, Katherine K Anagnostopoulou, Klelia D Salpea, Dimitri P Mikhailidis.   

Abstract

The insulin resistance/metabolic syndrome is characterized by the variable co-existence of hyperinsulinemia, obesity, dyslipidemia (small dense low-density lipoprotein, hypertriglyceridemia, and decreased high-density lipoprotein cholesterol), and hypertension. The pathogenesis of the syndrome has multiple origins. However, obesity and sedentary lifestyle coupled with diet and still largely unknown genetic factors clearly interact to produce the syndrome. This multifactorial and complex trait of metabolic syndrome leads to increased risk of cardiovascular disease. The scope of this review is to examine the differences in prevalence of the metabolic syndrome in various groups (eg, according to age, sex, ethnicity, social status, or presence of obesity) that could help with the better understanding of the pathogenesis of this syndrome. This review also considers the impact of metabolic syndrome on cardiovascular disease.

Entities:  

Mesh:

Year:  2007        PMID: 17570989     DOI: 10.1097/MAJ.0b013e318065c3a1

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  54 in total

1.  Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.

Authors:  Chao-Ping Wang; Fu-Mei Chung; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2007-08-10

2.  Association between intensive health guidance focusing on eating quickly and metabolic syndrome in Japanese middle-aged citizens.

Authors:  Daisuke Ekuni; Michiko Furuta; Toshihide Kimura; Naoki Toyama; Daiki Fukuhara; Yoko Uchida; Nanami Sawada; Manabu Morita
Journal:  Eat Weight Disord       Date:  2018-06-07       Impact factor: 4.652

3.  Prevalence of metabolic syndrome in turkmen ethnic groups in gorgan.

Authors:  Najmeh Shahini; Iman Shahini; Abdoljalal Marjani
Journal:  J Clin Diagn Res       Date:  2013-09-10

4.  The relevance of inflammatory markers in metabolic syndrome.

Authors:  Genel Sur; Emanuela Floca; Liana Kudor-Szabadi; Maria Lucia Sur; Daniel Sur; Gabriel Samasca
Journal:  Maedica (Buchar)       Date:  2014-03

5.  Association Between Elevated Liver Enzymes and Metabolic Syndrome Among Thai Adults.

Authors:  Sajithya Perera; Vitool Lohsoonthorn; Wiroj Jiamjarasrangsi; Somrat Lertmaharit; Michelle A Williams
Journal:  Diabetes Metab Syndr       Date:  2008-09

6.  Association of BDNF rs6265 and MC4R rs17782313 with metabolic syndrome in Pakistanis.

Authors:  Sobia Rana; Ayesha Sultana; Adil Anwar Bhatti
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

7.  The role of distubances of phosphate metabolism in metabolic syndrome.

Authors:  Marilena Stoian; Victor Stoica
Journal:  Maedica (Buchar)       Date:  2014-09

Review 8.  The epidemiology of obesity and gastrointestinal and other diseases: an overview.

Authors:  Paul Moayyedi
Journal:  Dig Dis Sci       Date:  2008-07-18       Impact factor: 3.199

9.  Linking Chronic Inflammation with Cardiovascular Disease: From Normal Aging to the Metabolic Syndrome.

Authors:  Angel Lopez-Candales; Paula M Hernández Burgos; Dagmar F Hernandez-Suarez; David Harris
Journal:  J Nat Sci       Date:  2017-04

10.  Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study.

Authors:  Jorge Escobedo; Herman Schargrodsky; Beatriz Champagne; Honorio Silva; Carlos P Boissonnet; Raul Vinueza; Marta Torres; Rafael Hernandez; Elinor Wilson
Journal:  Cardiovasc Diabetol       Date:  2009-09-26       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.